Search Results - "Friery, O. P."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N by GALLAGHER, R, HUGHES, C. M, MURRAY, M. M, FRIERY, O. P, PATTERSON, L. H, MCKEOWN, S. R, HIRST, D. G

    Published in British journal of cancer (17-08-2001)
    “…AQ4N is a bioreductive drug that can significantly enhance the anti-tumour effect of radiation and cyclophosphamide. The aim of this study was to examine the…”
    Get full text
    Journal Article
  2. 2

    Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine by FRIERY, O. P, GALLAGHER, R, MURRAY, M. M, HUGHES, C. M, GALLIGAN, E. S, MCINTYRE, I. A, PATTERSON, L. H, HIRST, D. G, MCKEOWN, S. R

    Published in British journal of cancer (01-04-2000)
    “…The ability of the bioreductive drugs AQ4N and tirapazamine to enhance the anti-tumour effect of cyclophosphamide was assessed in three murine tumour models…”
    Get full text
    Journal Article
  3. 3

    DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells by HEJMADI, M. V, MCKEOWN, S. R, FRIERY, O. P, MCINTYRE, I. A, PATTERSON, L. H, HIRST, D. G

    Published in British journal of cancer (01-02-1996)
    “…AQ4N (1,4-bis-([2-(dimethylamino-N- oxide)ethyl]amino)5,8-dihydroxyanthracene-9,10-dione) is a novel bioreductive agent that can be reduced to a stable,…”
    Get full text
    Journal Article
  4. 4

    Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation by McKeown, S R, Friery, O P, McIntyre, I A, Hejmadi, M V, Patterson, L H, Hirst, D G

    Published in British journal of cancer. Supplement (01-07-1996)
    “…The use of bioreductive drugs as an adjunct to radiotherapy in the treatment of cancer is presently being tested in several clinical trials worldwide. We have…”
    Get full text
    Journal Article
  5. 5

    The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N by Gallagher, R, Hughes, C M, Murray, M M, Friery, O P, Patterson, L H, Hirst, D G, McKeown, S R

    Published in British journal of cancer (18-11-2002)
    “…BRITISH JOURNAL OF CANCER: (2002) 87, 1339-1339. doi:10.1038/sj.bjc.6600561 www.bjcancer.com© 2002 Cancer Research UK CORRECTION TO:: British Journal of Cancer…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Royal Academy of Medicine in Ireland Section of Biomedical Sciences by Ruddock, W., Burns, D. M., Brown, J. C. W., Allen, J. M., Hirst, D. G., Love, G. P., Keenan, A. K., Lally, C., Bird, A., Ryan, M. P., O’Connor, N., O’Boyle, K. M., McGeown, J. G., McCarron, J. G., Drummond, R. M., Fay, F. S., Connor, T. J., Kelly, J. P., Leonard, B. E., Gilmartin, L., O’Cuinn, G., MacDonncha, C., Watson, A. W. S., McGrath, S., Brady, K. J., McKillen, H-C., Taylor, C. W., Smith, S. K., Thornton, S., Martin, A. D., Bailie, J. R., McKeown, S. R., Higgins, C. A., Hatton, W. J., McKerr, G., Harvey, D., Carson, J., Hannigan, B. M., Morrow, D. M. P., McGlynn, H., Thompson, C. M. G., Higgins, C., Galligan, E. S., Murray, M. M., Leckey, J. L., Nevin, G. B., Soppitt, D. S., Esfandiary, M. H., Gilmore, W. S., Robson, T., Dineen, T., Greer, A., Houghton, J. A., O’Halloran, K. D., Bradford, A., McGuire, M., MacDermott, M., Coogan, A., O’Connor, J. J., Regan, C. S., Redmond, A. M., Harkin, A., Lowe, A. S., Baxter, G. D., Kennovin, G. D., Leek, M., Friery, O. P., Hejmadi, M. V., Patterson, L. H., Robinson, J., Hill, I., Kilbride, J., Cotton, K. D., Hollywood, M. A., McHale, N. G., Thornbury, K. D., Halligan, C. P., O’Connell, D. P., Harvey, B. J., Fanning, P., O’Farrell, A., Cantillon, D., Cryan, J. F., O’Leary, D., O’Malley, D. T., Nolan, A., Moran, A. P., Fitzgerald, K. A., O’Neill, L. A. J., McElligott, A., Baker, A. H., Joyce, K. M., Ruane, T., Hall, W. J., Markos, F., Carey, M. F., Galvin, C., Perl, E. R., Curran, A. K., Connolly, C.

    Published in Irish journal of medical science (01-07-1997)
    Get full text
    Journal Article
  9. 9